MedTrace Logo

Soluble Fibrin for Diagnosing Pulmonary Embolism

NCT02438462 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2019-04-18

No results posted yet for this study

Summary

The purpose of the study is to evaluate the performances of Soluble Fibrin for diagnosing Pulmonary Embolism. Secondary objective is to compare the diagnostic performances of the Soluble Fibrin Assay and the D-Dimer test.

Conditions

  • Pulmonary Embolism (PE)

Interventions

OTHER

Soluble Fibrin

Calculating the area under the ROC curve of the Soluble Fibrin assay for the diagnosis of PE before evaluating the diagnostic performance of the assay.

Sponsors & Collaborators

  • European Georges Pompidou Hospital

    collaborator OTHER

  • Diagnostica Stago R&D

    lead INDUSTRY

Principal Investigators

  • Guy Meyer, Ph D · Georges Pompidou European Hospital

  • Geneviève Contant, Ph D · Diagnostica Stago R&D

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02438462 on ClinicalTrials.gov